Retatrutide - Pharmaqo

Retatrutide, manufactured by Pharmaqo, contains pharmaceutical grade Retatrutide supplied in a verified 1 vial x 10 mg + 1 amp x 1 ml BAC water presentation.

Retatrutide belongs to the GLP-1 / GIP Receptor Agonist class and features an active half life of 7 days. Every batch undergoes strict quality control verification to ensure consistent concentration, purity, and reliable bioavailability throughout your protocol.

Primary benefits of Retatrutide:

        Supports high quality lean tissue development and physical performance;
        Manufactured under strict pharmaceutical standards by Pharmaqo;
        Consistent release profile with predictable half life kinetics (7 days);
        Verified batch purity and sterile packaging integrity.

Recommended administration and cycle guidelines:

Standard protocols for Retatrutide utilize a dosage range of 0.25-2.5 mg/week depending on individual experience and cycle objectives. Users should always monitor health markers and follow structured post cycle recovery guidelines when applicable.

Storage and handling:

Keep Retatrutide in its original protective carton away from direct sunlight, moisture, and heat sources.